Aignostics raises €5.0M Seed round
28 August 2020· Berlin, Germany· health, biotech, ai, industrial_software, b2b, pure_software
Aignostics will use the funds to expand its portfolio in pharmaceutical research and fund longer-term projects aimed at developing companion diagnostics (CDx) applications.
Investors
LeadBoehringer Ingelheim Venture Fund
Also participating
High-Tech GründerfondsIBB VenturesFuture Capital
About Aignostics
Stage
Series B
Headquarters
Berlin, Germany
Founded
2020
Team Size
51–200
Sectors
healthbiotechaiindustrial_softwareb2bpure_software
Source: https://www.bihealth.org/en/notices/aignostics-raises-5m-seed-round-to-advance-ai-powered-pathology